NCT05091749View on ClinicalTrials.gov

Detection of Significant Coronary Artery Disease by Promising Biomarker: A2A Adenosine Receptor (A2AR) Assays

NAActive, not recruitingINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

November 9, 2021

Primary Completion Date

March 10, 2024

Study Completion Date

December 1, 2025

Conditions
Chronic Coronary Syndromes
Interventions
BIOLOGICAL

blood samples

troponin measurement

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER